Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BreAK CRC Trial: STC-1010 in Unresectable Locally Advanced or Metastatic Colorectal Cancer
NCT06934538Phase 2Recruiting
- Sponsor
- Brenus Pharma
- Start
- Jun 2025
- Primary completion
- Jun 2028
- Modality
- Cancer Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of STC-1010 in colorectal cancer (CRC), sponsored by Brenus Pharma. Started Jun 2025; status: recruiting.
02
Drugs
STC-1010
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06934538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06934538.